XML 79 R68.htm IDEA: XBRL DOCUMENT v3.26.1
Segments of Business - Schedule of Segment Information (Details)
$ in Millions
 3 Months Ended
Apr. 24, 2026
USD ($)
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Segment revenues      
Total revenues   $ 105,380 $ 97,827
Other segment expense, net      
Total other segment expense, net   103,804 96,534
Segment operating profit      
Subtotal   1,576 1,293
Interest expense   (77) (49)
Income before income taxes   1,308 1,051
Segment depreciation and amortization      
Total segment depreciation and amortization   195 157
Segment expenditures for long-lived assets      
Total segment expenditures for long-lived assets   $ 152 189
Number of reportable segments | segment   4  
Provision (credit) for bad debts   $ 45 196
Credits associated with last-in, first-out inventory method   (2) (7)
Restructuring charges   136 47
National Prescription Opioid Litigation      
Segment expenditures for long-lived assets      
Loss contingency, reduction of accrual $ 32    
Medical-Surgical Solutions      
Segment expenditures for long-lived assets      
Business separation costs   45  
Operating Segments | North American Pharmaceutical      
Segment revenues      
Total revenues   86,773 82,729
Other segment expense, net      
Total other segment expense, net   85,870 82,135
Segment operating profit      
Subtotal   903 594
Segment depreciation and amortization      
Total segment depreciation and amortization   39 32
Segment expenditures for long-lived assets      
Total segment expenditures for long-lived assets   $ 64 $ 61
Revenue derived from services (less than) (as a percent)   1.00% 1.00%
Provision (credit) for bad debts     $ 189
Restructuring charges   $ 2 1
Operating Segments | Oncology & Multispecialty      
Segment revenues      
Total revenues   14,222 10,658
Other segment expense, net      
Total other segment expense, net   13,897 10,446
Segment operating profit      
Subtotal   325 212
Segment depreciation and amortization      
Total segment depreciation and amortization   66 42
Segment expenditures for long-lived assets      
Total segment expenditures for long-lived assets   $ 18 $ 24
Revenue derived from services (less than) (as a percent)   7.00% 7.00%
Operating Segments | Prescription Technology Solutions      
Segment revenues      
Total revenues   $ 1,566 $ 1,434
Other segment expense, net      
Total other segment expense, net   1,340 1,181
Segment operating profit      
Subtotal   226 253
Segment depreciation and amortization      
Total segment depreciation and amortization   19 21
Segment expenditures for long-lived assets      
Total segment expenditures for long-lived assets   $ 0 $ 1
Revenue derived from services (less than) (as a percent)   39.00% 39.00%
Restructuring charges   $ 61  
Operating Segments | Medical-Surgical Solutions      
Segment revenues      
Total revenues   2,819 $ 2,701
Other segment expense, net      
Total other segment expense, net   2,697 2,480
Segment operating profit      
Subtotal   122 221
Segment depreciation and amortization      
Total segment depreciation and amortization   26 22
Segment expenditures for long-lived assets      
Total segment expenditures for long-lived assets   $ 27 $ 25
Revenue derived from services (less than) (as a percent)   1.00% 1.00%
Restructuring charges   $ 23 $ 17
Other      
Segment revenues      
Total revenues   0 305
Other segment expense, net      
Total other segment expense, net   0 292
Segment operating profit      
Subtotal   0 13
Segment depreciation and amortization      
Total segment depreciation and amortization   0 3
Segment expenditures for long-lived assets      
Total segment expenditures for long-lived assets   0 1
Corporate      
Segment operating profit      
Corporate expenses, net   (191) (193)
Segment depreciation and amortization      
Total segment depreciation and amortization   45 37
Segment expenditures for long-lived assets      
Total segment expenditures for long-lived assets   43 77
Restructuring charges   50 $ 29
Corporate | National Prescription Opioid Litigation      
Segment expenditures for long-lived assets      
Loss contingency, reduction of accrual   34  
Corporate | Medical-Surgical Solutions      
Segment expenditures for long-lived assets      
Business separation costs   $ 23